Developing a rich pipeline of options for HIV prevention is essential and must be guided by community priorities that define what products are needed and supported through R&D.

Once approved, interventions typically become widely available in wealthy countries within a few years time. But scaling up new options in lower and middle-income countries lags for years, even decades, with devastating effects on global health, individual lives, and the global effort to end the epidemic.

AVAC’s work supports:

• Development of timely, efficient, effective and affordable prevention options
• Including community needs and perspectives in R&D
• Getting products faster to market and to scale
• Understanding the products’ users
• Compiling and analyzing market data
• Sharing information
• Bringing effective prevention options to those who need them